Menu
Peter Lio, MD, Assistant Professor of Clinical Dermatology and Pediatrics at Northwestern University’s Feinberg School of Medicine, discusses the development of JAK inhibitors over the years, and reviews the increase in reliability among both oral and topical treatments for atopic dermatitis.
Douglas DiRuggiero, DMSc, PA-C, discusses the mechanism of action and efficacy of topical and systemic JAK inhibitors for the treatment of atopic dermatitis.
Douglas DiRuggiero, DMSc, PA-C, discusses the exciting renaissance occurring in the realm of topical treatments for atopic dermatitis.
Lisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist with Ada West Dermatology in Boise, Idaho, reviews the role that Janus kinases (JAKs) play in the inflammatory process and the benefits of inhibiting this enzyme when treating patients with atopic dermatitis. She also elaborates upon her experiences using the newly approved JAK inhibitors in her own patients. Dr. Swanson then outlines things to consider before starting patients on JAK inhibitors.
Matthew Zirwas, MD, discusses the efficacy, benefits, and safety profile of topical and systemic JAK inhibitors for the treatment of atopic dermatitis.
Lisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist with Ada West Dermatology in Boise, Idaho, discusses how she intends to incorporate newly approved JAK inhibitors into her atopic dermatitis treatment algorithm and her strategies for patient counseling when treating with these agents.
Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medicine, discusses how he addresses questions from his patients with AD regarding potential adverse events and warnings associated with treatments for AD.
Matthew Zirwas, MD, provides guidance on speaking with patients with atopic dermatitis about treating their condition with topical JAK inhibitors.
Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medicine, reviews the mechanisms of action of currently available treatments for atopic dermatitis, including JAK inhibitors and biologic medications, and details how these medications work differently to reduce inflammation associated with the disease.
Dr. James Del Rosso reviews various common treatments for atopic dermatitis, specifically topical agents that have demonstrated effectiveness for patients.
Dr. James Del Rosso discusses the benefits of topical JAK inhibitors over oral JAK inhibitors for the treatment of atopic dermatitis.